|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/04 | |
| A61K 31/4709 | |||
| A61P 31/04 |
| (11) | Number of the document | 3112359 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16177827.9 |
| Date of filing the European patent application | 2012-11-09 | |
| (97) | Date of publication of the European application | 2017-01-04 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-21 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 2011246209 | 2011-11-10 | JP | |
| 2012071739 | 2012-03-27 | JP |
| (72) |
Araya, Ichiro, JP
Goto, Akinori, JP
Minagawa, Wataru, JP
Funada, Keiko, JP
Nagao, Muneki, JP
|
| (73) |
Kyorin Pharmaceutical Co., Ltd.,
6, Kanda Surugadai 4-chome Chiyoda-ku, Tokyo 101-8311,
JP
|
| (54) | 7-{(3S,4S)-3-[(CYCLOPROPYLAMINO)METHYL]-4-FLUOROPYRROLIDINE-1-YL}-6-FLUORO-1-(2-FLUOROETHYL)-8-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID CRYSTAL |
| 7-{(3S,4S)-3-[(CYCLOPROPYLAMINO)METHYL]-4-FLUOROPYRROLIDINE-1-YL}-6-FLUORO-1-(2-FLUOROETHYL)-8-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID CRYSTAL |